Newest first. 5.2k questions across 107 tags.
Details up front: a GLP-1 receptor agonist · 2–8 °C · seven days. This is a planning question. I know what my options are; I do not know how to weigh them. What I…
Concretely: ferritin · oral semaglutide. I want to know whether this is a real physical effect or an artefact of how it is measured. What prompted the question is an…
The case in front of me: ESSENCE · oral semaglutide. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me…
The case in front of me: 4 mg/mL · tirzepatide. I would like the axes of comparison first and the recommendation second. I have tried the first option and it works;…
Concretely: semaglutide · a C4 column · semaglutide. I would like the axes of comparison first and the recommendation second. I have tried the first option and it…
I am comparing a supplier certificate against an independent result on the same lot. Please show the division. I want to check my own against yours. I would like the…
The case in front of me: Homopeptide · GGPeps · Poland. I would like the axes of comparison first and the recommendation second. I have tried the first option and it…
Concretely: CPC · liraglutide. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result, which I…
My laboratory results are from the same laboratory each time, drawn fasting, which I gather matters. Please show the division. I want to check my own against yours. I…
Conditions: PIONEER-4 · reflux · 60 mg. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result,…
For reference: MKM · Hunan Aslsen Technology. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments for each and…
The particulars: tirzepatide · list of related substances. I want to understand what this actually establishes, as opposed to what it is being used to imply. My…
The particulars: cystatin C · ecnoglutide. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping…
What I am working with: 98.4% · a GLP-1 receptor agonist. I have worked this out and I would like someone to find the error, because I suspect there is one. My…
I have kept a symptom diary against dose dates, which turns out to have been the useful thing. Both of these get recommended confidently by different people, which…
Stated plainly: 1 mg/mL · mazdutide. Both of these get recommended confidently by different people, which suggests neither is obviously right. My constraints are…
What I am working with: headache · cagrilintide. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious. My…
What I am working with: a formic acid mobile phase · a GLP-1 receptor agonist · a wide-pore C18 column. I keep seeing this stated as a fact with no explanation…
This is a first order from this supplier, so I have no track record to reason from. I would like help reading this properly rather than being told what conclusion to…
Numbers first: cagrilintide · STEP 8. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
Details up front: a wine cooler · dulaglutide. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which…
Numbers first: ATTAIN-1 · dulaglutide. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
Numbers first: SWB · Shanghai ERP Biotechnology. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
What I have: WWB · BCH · Norway. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is reproducibility,…